AbbVie Stock Slips as Q1 Earnings Expected to Drop Despite Premium Valuation
• AbbVie (ABBV) stock fell 0.59% while the S&P 500 fell 0.19% and the Dow gained 0.1%
• ABBV earnings per share projected to drop 4.88% year-over-year next quarter
• Revenue estimated to fall 2.31% year-over-year next quarter
• Analyst estimate revisions associate directly with imminent stock price changes
• ABBV valuation marks a premium compared to industry average Forward P/E ratio